Acasti Pharma Inc. announced that Mr. Jean-Marie (John) Canan had tendered his resignation from the Board of Directors of the Company, such resignation to take effect immediately. Mr. Canan was also a member of the Company's audit committee and governance and human resources committee. Mr. Canan's resignation was not the result of any dispute or disagreement with the Company or the Company's board of directors on any matter relating to the operations, policies or practices of the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.76 USD | +2.22% | -0.00% | -4.50% |
Feb. 12 | Acasti Pharma Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 | CI |
Feb. 07 | Craig-Hallum Initiates Acasti Pharma With Buy Rating, $6 Price Target | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.50% | 25.94M | |
+32.36% | 694B | |
+29.78% | 593B | |
-1.60% | 371B | |
+20.07% | 331B | |
+6.04% | 290B | |
+14.40% | 239B | |
-3.48% | 209B | |
+10.04% | 209B | |
+9.27% | 169B |
- Stock Market
- Equities
- ACST Stock
- News Acasti Pharma Inc.
- Acasti Pharma Inc. Announces Resignation of Jean-Marie Canan from Board of Directors and Member of Audit Committee and Governance and Human Resources Committee